Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8058 USD | +2.65% | +0.60% | -32.85% |
Business Summary
Number of employees: 18
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 20-10-31 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-07 |
Barbara Ryan
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 14-04-30 |
Alan Walts
BRD | Director/Board Member | 64 | 21-03-31 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Lindsay Androski
BRD | Director/Board Member | - | 22-07-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,143,390 | 3,006,085 ( 95.63 %) | 0 | 95.63 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.85% | 2.66M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ELOX Stock
- Company Eloxx Pharmaceuticals, Inc.